Zum Hauptinhalt springen

Buprenorphin

18. August 2026 | Buprenorphin

Patient Experience of Withdrawal During Methadone-Buprenorphine Transfer: A Prospective Cohort Study.

Patient Experience of Withdrawal During Methadone-Buprenorphine Transfer: A Prospective Cohort Study. Tremonti C, Mills L, Lintzeris N, Blogg J, Jamshidi N, Harjanto R, Blazey A, Montebello M, Ismay C, Page R, Buckley NA, Perananthan V, Haber PS.&n…

18. August 2026 | Buprenorphin

Reconsidering the usefulness of using long-acting injectable buprenorphine as a tapering tool: a case report of delayed withdrawal months after last dose.

Reconsidering the usefulness of using long-acting injectable buprenorphine as a tapering tool: a case report of delayed withdrawal months after last dose. Woods K, Graham S, Dobscha S, Blazes C. Front Psychiatry. 2026 Jul 6;17:1863924…

16. August 2026 | Buprenorphin

Considerations for implementing high-dose buprenorphine for opioid use disorder.

Considerations for implementing high-dose buprenorphine for opioid use disorder. Mitragotri, S. and Zhu, D.T. (2025), Addiction, 120: 1282-1283. doi.org/10.1111/add.70051 https://onlinelibrary.wiley.com/doi/10.1111/add.70051

16. August 2026 | Buprenorphin

Dose-specific clinical outcomes in patients with opioid use disorder treated with 24-32 mg/day of buprenorphine.

Dose-specific clinical outcomes in patients with opioid use disorder treated with 24-32 mg/day of buprenorphine. D'Agata Mount J, Sun J, Davis A, Cover A, Sun L, Gannon C, Derenoncourt M, Garrett G, Eyasu R, Ebah E, Bijole P, Greenblatt A, Ka…

02. August 2026 | Buprenorphin

Perceptions of Buprenorphine With Naloxone Treatment and the Fear of Precipitated Withdrawal: A Qualitative Exploration With HIV Prevention Trials Network 094 INTEGRA Participants and Staff.

Perceptions of Buprenorphine With Naloxone Treatment and the Fear of Precipitated Withdrawal: A Qualitative Exploration With HIV Prevention Trials Network 094 INTEGRA Participants and Staff. Schmidt RA, Perez-Brumer A, Davidson P, Shoptaw S…

02. August 2026 | Buprenorphin

Buprenorphine-Naloxone vs Extended-Release Naltrexone Following Opioid Withdrawal Treatment.

Buprenorphine-Naloxone vs Extended-Release Naltrexone Following Opioid Withdrawal Treatment. Hsu HE, Lodi S, Yan S, et al. JAMA Netw Open. 2026;9(7):e2623280. doi:10.1001/jamanetworkopen.2026.23280 https://jamanetwork.c…

02. August 2026 | Buprenorphin

Can Buprenorphine Be Overdosed? The Ceiling Effect and Its Clinical Implications.

Can Buprenorphine Be Overdosed? The Ceiling Effect and Its Clinical Implications. Kozińska RB, Ślęzak J, Ilski I, Podsiadła M, Biedka K, Królewicz E. Pharmaceuticals (Basel). 2026 Jun 6;19(6):903. doi: 10.3390/ph19060903. PMID: 4235652…

Weitere
akutelle Informationen
zu den Themengebieten